BioSpace News Archive

Herbalife Nutrition announced its support for the American Red Cross #MissingType campaign.

AIVITA Biomedical announced that it has raised $15 million in a private Series B financing round.

Can-Fite BioPharma Ltd. today provided an update on new pre-clinical data supporting the selection of the primary endpoint for the current ongoing Phase II study in NAFLD/NASH patients.

More patients in England and Wales with chronic DME could benefit from low-dose corticosteroid intravitreal implant that lasts up to three years

Collaboration provides opportunity to expand on Alexion’s two decades of complement leadership

Khiron Life Sciences Corp. announced that it has received endorsements and signed co-operation agreements with two of the largest and most recognized medical associations in the country:

Rubin succeeds Paul Geyer, who will remain a Director of the Board.

CheckedUp multimedia system will provide targeted disease and research information to retinal-disease patients in waiting and exam rooms at 1,000 ophthalmology practices in US.

China Biologic Products Holdings, Inc. announced that Shandong Taibang Biological Products Co. Ltd., the Company’s majority-owned subsidiary, recently obtained approval from the China Food and Drug Administration (the “CFDA”) to begin human clinical trials on its Human Fibrin Sealant (“Fibrin Sealant”) product.

Promising compound has potential for treatment of Molybdenum Cofactor Deficiency Type A, an inborn error of metabolism